
Insights from 2023 ESMO Asia Annual Meeting
Video Player is loading.
ESMO Asia 2023 Insights: "KEYNOTE-811 Study of Pembro + Trastuzumab & Chemo for HER2+ Metastatic Gastric/GEJ Adenocarcinoma"
By
Insights from 2023 ESMO Asia Annual Meeting
FEATURING
Sun Young Rha
By
Insights from 2023 ESMO Asia Annual Meeting
FEATURING
Sun Young Rha
Comments 0
Login to view comments.
Click here to Login